Related references
Note: Only part of the references are listed.
Review
Infectious Diseases
Joan B. Soriano et al.
Summary: People with COVID-19 might experience long-term symptoms known as long COVID or long-haul COVID. The lack of a standardized definition hinders the understanding and treatment of this condition. In a WHO-led Delphi process, a consensus definition was developed, stating that post-COVID-19 condition occurs in individuals with a history of SARS-CoV-2 infection, with symptoms lasting for at least 2 months and impacting everyday functioning. This common framework provides a foundation for future studies and therapy.
LANCET INFECTIOUS DISEASES
(2022)
Article
Biotechnology & Applied Microbiology
Ibrahim Mohammed et al.
Summary: This article compares the efficacy and effectiveness of seven COVID-19 vaccines through a systematic review, revealing that these vaccines have successfully reduced infection rates, severity, hospitalization, and mortality. The full-dose regimen of the Pfizer/BioNTech vaccine shows the highest effectiveness against various variants.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2022)
Article
Infectious Diseases
Rosa Maria Wong-Chew et al.
Summary: This study reports on the prevalence and associated risk factors of long-term health consequences of COVID-19 in patients discharged from a temporary COVID-19 hospital in Mexico City. Neurological, dermatological, and mood disorder symptoms were found to persist in over 30% of patients at 90 days post-discharge. While most symptoms decreased in frequency between day 30 and 90, alopecia and the dermatological symptom cluster significantly increased. Women were more prone to develop long-term symptoms, and invasive mechanical ventilation also increased the frequency of symptoms at 30 days post-discharge.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE
(2022)
Article
Immunology
Jessica Seessle et al.
Summary: Long COVID, defined as persistent symptoms after SARS-CoV-2 infection, can last for at least 1 year and significantly impact life quality. Neurocognitive symptoms, possibly related to autoimmunity indicated by elevated ANA titers, are more common in females and can persist even when SARS-CoV-2 antibody levels are not significantly different from patients without symptoms.
CLINICAL INFECTIOUS DISEASES
(2022)
Article
Clinical Neurology
Ilona Merikanto et al.
Summary: During the COVID-19 pandemic, evening-types experienced poorer mental health, well-being, and quality of life compared to other circadian types. They also reported delayed sleep-wake schedules, increased sleep duration, and more severe sleep problems. Meanwhile, morning-types were less vulnerable to sleep changes and experienced protection from most sleep problems.
Review
Virology
Benjamin Gallo Marin et al.
Summary: The severity and mortality of COVID-19 may be associated with patient age, multiple comorbidities, hypoxia, extensive lung involvement on CT scans, laboratory abnormalities, and biomarkers of end-organ dysfunction.
REVIEWS IN MEDICAL VIROLOGY
(2021)
Editorial Material
Medicine, General & Internal
Anthony L. Komaroff et al.
FRONTIERS IN MEDICINE
(2021)
Article
Medicine, General & Internal
Markku Partinen et al.
Summary: Sleep problems, fatigue, and excessive sleepiness significantly increased worldwide during the first phase of the COVID-19 pandemic, with associations with confinement measures and especially financial difficulties.
Review
Multidisciplinary Sciences
Xinyang Li et al.
Summary: The study identified potential risk factors for severe COVID-19 cases, including advanced age, male gender, obesity, smoking history, hypertension, diabetes, coronary heart disease, chronic kidney disease, cerebrovascular disease, chronic obstructive pulmonary disease, malignancy, and chronic liver disease. Acute respiratory distress syndrome, shock, and acute kidney injury were found to be major hindrances to recovery.
Article
Medicine, General & Internal
Daniel Ayoubkhani et al.
Summary: Patients discharged from the hospital after COVID-19 were found to have increased rates of multiorgan dysfunction, with higher risk not only limited to the elderly but also varying across ethnic groups.
BMJ-BRITISH MEDICAL JOURNAL
(2021)
Article
Multidisciplinary Sciences
Sandra Lopez-Leon et al.
Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.
SCIENTIFIC REPORTS
(2021)
Review
Cell Biology
Hong Fang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
(2019)
Article
Clinical Neurology
Charles M. Morin et al.
